A metabolomics cell-based approach for anticipating and investigating drug-induced liver injury.
Ontology highlight
ABSTRACT: In preclinical stages of drug development, anticipating potential adverse drug effects such as toxicity is an important issue for both saving resources and preventing public health risks. Current in vitro cytotoxicity tests are restricted by their predictive potential and their ability to provide mechanistic information. This study aimed to develop a metabolomic mass spectrometry-based approach for the detection and classification of drug-induced hepatotoxicity. To this end, the metabolite profiles of human derived hepatic cells (i.e., HepG2) exposed to different well-known hepatotoxic compounds acting through different mechanisms (i.e., oxidative stress, steatosis, phospholipidosis, and controls) were compared by multivariate data analysis, thus allowing us to decipher both common and mec
SUBMITTER: Garcia-Canaveras JC
PROVIDER: S-EPMC4893700 | biostudies-literature | 2016 Jun
REPOSITORIES: biostudies-literature
ACCESS DATA